Zobrazeno 1 - 10
of 18
pro vyhledávání: '"M A, Creager"'
Publikováno v:
Journal of applied biomaterialsbiomechanics : JABB. 5(3)
Even before material science was a recognized discipline, the amazing mechanical properties of spider silk were documented and became the object of much study. In addition to the exceptional material properties of spider silk and the reported low imm
Autor:
M A, Creager
Publikováno v:
Reviews in cardiovascular medicine. 2(4)
Takayasu arteritis is a severe inflammatory vascular disorder that can involve the thoracic or abdominal aorta and their branches as well as the pulmonary artery. It has a much higher incidence in women than in men, and is most frequently found in As
Autor:
J M, Garasic, M A, Creager
Publikováno v:
Reviews in cardiovascular medicine. 2(3)
Patients with peripheral arterial disease frequently develop symptoms of claudication that interfere with ambulation and adversely affect quality of life, and some develop critical limb ischemia. Many of these patients have coexisting coronary artery
Autor:
W R, Hiatt, J G, Regensteiner, M A, Creager, A T, Hirsch, J P, Cooke, J W, Olin, G N, Gorbunov, J, Isner, Y V, Lukjanov, M S, Tsitsiashvili, T F, Zabelskaya, A, Amato
Publikováno v:
The American journal of medicine. 110(8)
We tested the hypothesis that propionyl-L-carnitine would improve peak walking time in patients with claudication. Secondary aims of the study were to evaluate the effects of propionyl-L-carnitine on claudication onset time, functional status, and sa
Autor:
A T, Chan, A, Atiemo, L K, Diran, G P, Licholai, P, McLaren Black, M A, Creager, S Z, Goldhaber
Publikováno v:
Journal of thrombosis and thrombolysis. 8(2)
Most Neurosurgical Service patients at our hospital receive venous thromboembolism prophylaxis. In 1995-96, the rate of clinically overt venous thromboembolism was 3.7% among patients undergoing neurosurgery. However, rates were much higher when cran
Autor:
M A, Creager
Publikováno v:
Vascular medicine (London, England). 3(3)
The recent CAPRIE trial (clopidogrel versus aspirin in patients at risk of ischaemic events) compared clopidogrel with aspirin in reducing the risk of vascular events in 19,185 patients with clinical manifestations of atherosclerosis. Participants we
Publikováno v:
Circulation. 98(4)
Publikováno v:
The Journal of arthroplasty. 9(2)
Orthopedic patients are at a high risk for developing venous thromboembolism, yet only a fraction of eligible patients receive anticoagulation prophylaxis after hospital discharge. This pilot study compared the efficacy of a fixed 2 mg/d dose of warf
Autor:
J A, Spittell, N C, Nanda, M A, Creager, J L, Ochsner, G, Dorros, L, Wexler, J M, Isner, J R, Young
Publikováno v:
Journal of the American College of Cardiology. 22(2)
Each trainee in vascular medicine must be eligible for the board certification examination of the American Board of Internal Medicine or its equivalent. Training faculty, preferably at least two members, should meet the qualifications and training re
Publikováno v:
Journal of the American College of Cardiology. 22(1)
The aim of this study was to assess the efficacy of flosequinan in chronic heart failure.Flosequinan is a new vasodilator drug that acts by interfering with the inositol-triphosphate/protein kinase C pathway, an important mechanism of vasoconstrictio